首页 > 最新文献

Polimery w medycynie最新文献

英文 中文
Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. 左西替利嗪口服快速崩解片的研制与表征。
Q3 Medicine Pub Date : 2018-01-01 DOI: 10.17219/pim/99951
Samvedn Samvedna, Shammy Jindal, Gaurav Mishra, Jyotsana R Madan, Gaurav Gupta, Rajendra Awasthi, Terezinha De Jesus Andreoli Pinto, Kamal Dua, Giriraj T Kulkarni

Background: Levocetirizine, active R (-) enantiomer of cetirizine, is an orally active and selective H1 receptor antagonist used medically as an anti-allergic. Allergic rhinitis is a symptomatic disorder of the nose induced by inflammation mediated by immunoglobulin E (IgE) in the membrane lining the nose after allergen exposure.

Objectives: The purpose of the present study was to prepare rapidly disintegrating tablets of levocetirizine after its complexation with β-cyclodextrin (β-CD).

Material and methods: Levocetirizine-β-CD complex tablets were prepared by direct compression technique using 3 synthetic superdisintegrants in different proportions. Development of the formulation in the present study was mainly based on the concentration of superdisintegrants and the properties of the drug. Nine batches of tablets were formulated and evaluated for various parameters: drug content, weight variation, water absorption ratio, wetting time, in vitro disintegration, hardness, friability, thickness uniformity, and in vitro dissolution.

Results: A Fourier-transform infrared spectroscopy (FTIR) study showed that there were no significant interactions between the drug and the excipients. The prepared tablets were good in appearance and showed acceptable results for hardness and friability. The in vitro disintegrating time of the formulated tablet batches was found to be 15-35 s percentage and the drug content of tablets in all formulations was found to be between 90-102%, which complied with the limits established in the United States Pharmacopeia.

Conclusions: Complexation of levocetirizine with β-CD significantly improves the solubility of the drug. The disintegration time of the tablets was decreased with an increase in superdisintegrant amount. The tablets (batch CPX5) had a minimum disintegration time of 20 s and 99.99% of the drug was released within 10 min.

背景:左西替利嗪是西替利嗪的活性R(-)对映体,是一种具有口服活性和选择性的H1受体拮抗剂,医学上用作抗过敏药物。变应性鼻炎是过敏原暴露后,由鼻粘膜免疫球蛋白E (IgE)介导的炎症引起的鼻部症状性疾病。目的:制备左西替利嗪与β-环糊精(β-CD)络合快速崩解片。材料与方法:采用3种不同比例的合成超崩解剂,采用直接压缩法制备左西替利嗪-β-CD复合片。本研究主要根据超崩解剂的浓度和药物的性质来开发配方。对9批制剂的药物含量、重量变化、吸水率、润湿时间、体外崩解、硬度、脆性、厚度均匀性、体外溶出度等参数进行评价。结果:傅里叶红外光谱(FTIR)研究表明,该药物与辅料之间没有明显的相互作用。所制片剂外观美观,硬度和脆度均可接受。制剂批次的体外崩解时间为15 ~ 35s %,各制剂的药物含量在90 ~ 102%之间,符合美国药典规定的限量标准。结论:左西替利嗪与β-CD络合可显著提高药物的溶解度。随着超崩解剂用量的增加,崩解时间缩短。CPX5批崩解时间最短20 s, 10 min内释药率达99.99%。
{"title":"Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.","authors":"Samvedn Samvedna,&nbsp;Shammy Jindal,&nbsp;Gaurav Mishra,&nbsp;Jyotsana R Madan,&nbsp;Gaurav Gupta,&nbsp;Rajendra Awasthi,&nbsp;Terezinha De Jesus Andreoli Pinto,&nbsp;Kamal Dua,&nbsp;Giriraj T Kulkarni","doi":"10.17219/pim/99951","DOIUrl":"https://doi.org/10.17219/pim/99951","url":null,"abstract":"<p><strong>Background: </strong>Levocetirizine, active R (-) enantiomer of cetirizine, is an orally active and selective H1 receptor antagonist used medically as an anti-allergic. Allergic rhinitis is a symptomatic disorder of the nose induced by inflammation mediated by immunoglobulin E (IgE) in the membrane lining the nose after allergen exposure.</p><p><strong>Objectives: </strong>The purpose of the present study was to prepare rapidly disintegrating tablets of levocetirizine after its complexation with β-cyclodextrin (β-CD).</p><p><strong>Material and methods: </strong>Levocetirizine-β-CD complex tablets were prepared by direct compression technique using 3 synthetic superdisintegrants in different proportions. Development of the formulation in the present study was mainly based on the concentration of superdisintegrants and the properties of the drug. Nine batches of tablets were formulated and evaluated for various parameters: drug content, weight variation, water absorption ratio, wetting time, in vitro disintegration, hardness, friability, thickness uniformity, and in vitro dissolution.</p><p><strong>Results: </strong>A Fourier-transform infrared spectroscopy (FTIR) study showed that there were no significant interactions between the drug and the excipients. The prepared tablets were good in appearance and showed acceptable results for hardness and friability. The in vitro disintegrating time of the formulated tablet batches was found to be 15-35 s percentage and the drug content of tablets in all formulations was found to be between 90-102%, which complied with the limits established in the United States Pharmacopeia.</p><p><strong>Conclusions: </strong>Complexation of levocetirizine with β-CD significantly improves the solubility of the drug. The disintegration time of the tablets was decreased with an increase in superdisintegrant amount. The tablets (batch CPX5) had a minimum disintegration time of 20 s and 99.99% of the drug was released within 10 min.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"48 1","pages":"31-40"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36876565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast. 阿普米司特微波辅助固体分散体片的制备、表征及体外评价。
Q3 Medicine Pub Date : 2018-01-01 DOI: 10.17219/pim/99801
Jyotsana R Madan, Akshaya R Pawar, Rajesh B Patil, Rajendra Awasthi, Kamal Dua

Background: Solid dispersions are among the techniques successfully employed to enhance the dissolution of poorly water-soluble drugs. Microwave (MW)-assisted evaporative crystallization has been used to prepare solid dispersions of drugs and polymers.

Objectives: The aim of the study was to investigate the solubility of apremilast (APM) in water by exploring the effect of MW-assisted solid dispersion technology.

Material and methods: In the present study, solid dispersions of APM, a poorly water-soluble drug, were prepared. The solid dispersions were prepared using the conventional method (CM) and the MW-based solvent evaporation technique. Microwave energy was used to enhance the solubility and dissolution rate of APM. The physical mixture and solid dispersions were characterized using Fourier-transform infrared spectroscopy (FTIR), X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). Apremilast tablets containing MW-assisted solid dispersions were prepared by the direct compression technique and compared with the marketed formulation (Aprezo tablets).

Results: The results obtained confirmed the conversion of crystalline APM to an amorphous form. The XRPD pattern of the MW-assisted formulation at a 2:1 ratio suggests the amorphous structure of APM within the formulation. Based on solubility studies results, Syloid® 244FP was selected as the best carrier. The dissolution study results suggested that the APM tablet prepared using MW-assisted solid dispersions at a 2:1 carrier/drug ratio improved the APM dissolution rate compared to the marketed formulation.

Conclusions: Based on the results, it can be concluded that the MW-assisted solid dispersion technique may be an effective approach to enhancing the dissolution profile of other poorly water-soluble drugs.

背景:固体分散体是提高水溶性差药物溶出度的成功技术之一。微波辅助蒸发结晶已被用于制备药物和聚合物的固体分散体。目的:研究毫米波辅助固体分散技术对阿普米司特(APM)在水中溶解度的影响。材料与方法:制备了难水溶性药物APM的固体分散体。采用常规方法(CM)和基于mw的溶剂蒸发技术制备固体分散体。利用微波能提高APM的溶解度和溶解速率。采用傅里叶变换红外光谱(FTIR)、x射线粉末衍射(XRPD)、差示扫描量热法(DSC)和扫描电镜(SEM)对物理混合物和固体分散体进行了表征。采用直接压缩技术制备了含有mw辅助固体分散体的阿普瑞司特片,并与市售阿普瑞司特片进行了比较。结果:得到的结果证实了结晶型APM向非晶态的转变。在2:1的比例下,微波辅助配方的XRPD图显示了配方中APM的非晶结构。基于溶解度研究结果,Syloid®244FP被选为最佳载体。溶出度研究结果表明,与市售制剂相比,以2:1的载药比采用微波辅助固体分散体制备的APM片提高了APM的溶出度。结论:微波辅助固体分散技术可能是提高其他难水溶性药物溶出度的有效方法。
{"title":"Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.","authors":"Jyotsana R Madan,&nbsp;Akshaya R Pawar,&nbsp;Rajesh B Patil,&nbsp;Rajendra Awasthi,&nbsp;Kamal Dua","doi":"10.17219/pim/99801","DOIUrl":"https://doi.org/10.17219/pim/99801","url":null,"abstract":"<p><strong>Background: </strong>Solid dispersions are among the techniques successfully employed to enhance the dissolution of poorly water-soluble drugs. Microwave (MW)-assisted evaporative crystallization has been used to prepare solid dispersions of drugs and polymers.</p><p><strong>Objectives: </strong>The aim of the study was to investigate the solubility of apremilast (APM) in water by exploring the effect of MW-assisted solid dispersion technology.</p><p><strong>Material and methods: </strong>In the present study, solid dispersions of APM, a poorly water-soluble drug, were prepared. The solid dispersions were prepared using the conventional method (CM) and the MW-based solvent evaporation technique. Microwave energy was used to enhance the solubility and dissolution rate of APM. The physical mixture and solid dispersions were characterized using Fourier-transform infrared spectroscopy (FTIR), X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). Apremilast tablets containing MW-assisted solid dispersions were prepared by the direct compression technique and compared with the marketed formulation (Aprezo tablets).</p><p><strong>Results: </strong>The results obtained confirmed the conversion of crystalline APM to an amorphous form. The XRPD pattern of the MW-assisted formulation at a 2:1 ratio suggests the amorphous structure of APM within the formulation. Based on solubility studies results, Syloid® 244FP was selected as the best carrier. The dissolution study results suggested that the APM tablet prepared using MW-assisted solid dispersions at a 2:1 carrier/drug ratio improved the APM dissolution rate compared to the marketed formulation.</p><p><strong>Conclusions: </strong>Based on the results, it can be concluded that the MW-assisted solid dispersion technique may be an effective approach to enhancing the dissolution profile of other poorly water-soluble drugs.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"48 1","pages":"17-24"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36877130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Dialysis membranes: A 2018 update. 透析膜:2018年更新。
Q3 Medicine Pub Date : 2018-01-01 DOI: 10.17219/pim/102974
Piotr Olczyk, Artur Małyszczak, Mariusz Kusztal

Dialysis membranes are the basic element of a hemodialyzer. Synthetic and natural materials characterized by various fiber arrangements are used in their production. The most up-to-date ones are made of synthetic polymers such as polyamide, phosphatidylserine (PS), polyacrylonitrile-based fiber (PAN), polyarylethersulfone, polyethersulfone, or polymethylmethacrylate. Dialysis membranes are characterized by the ability to remove uremic molecules, which can be divided into small water-soluble compounds, protein-bound compounds and larger "middle molecules". Newer membranes such as medium cut off membranes (MCO) allow the removal of a wider spectrum of uremic molecules, which reduces the risk of late complications of dialysis. Dialysis membranes are used in therapy methods such as low flux, high flux or HDx therapy. An important aim in dialysis membrane development is to increase their biocompatibility. Insufficient biocompatibility can result in complement activation or platelet activation, which can lead to an increased risk of cardiovascular complications. The aim of the study is to discuss the latest reports on dialysis membranes.

透析膜是血液透析器的基本组成部分。以各种纤维排列为特征的合成材料和天然材料用于其生产。最新的是由合成聚合物制成的,如聚酰胺、磷脂酰丝氨酸(PS)、聚丙烯腈基纤维(PAN)、聚芳醚砜、聚醚砜或聚甲基丙烯酸甲酯。透析膜的特点是能够去除尿毒症分子,这些分子可分为小的水溶性化合物、蛋白质结合化合物和较大的“中间分子”。较新的膜,如介质切断膜(MCO)可以去除更广泛的尿毒症分子,从而降低透析后期并发症的风险。透析膜用于治疗方法,如低通量、高通量或HDx治疗。提高透析膜的生物相容性是透析膜发展的一个重要目标。生物相容性不足可导致补体活化或血小板活化,从而增加心血管并发症的风险。本研究的目的是讨论透析膜的最新报道。
{"title":"Dialysis membranes: A 2018 update.","authors":"Piotr Olczyk,&nbsp;Artur Małyszczak,&nbsp;Mariusz Kusztal","doi":"10.17219/pim/102974","DOIUrl":"https://doi.org/10.17219/pim/102974","url":null,"abstract":"<p><p>Dialysis membranes are the basic element of a hemodialyzer. Synthetic and natural materials characterized by various fiber arrangements are used in their production. The most up-to-date ones are made of synthetic polymers such as polyamide, phosphatidylserine (PS), polyacrylonitrile-based fiber (PAN), polyarylethersulfone, polyethersulfone, or polymethylmethacrylate. Dialysis membranes are characterized by the ability to remove uremic molecules, which can be divided into small water-soluble compounds, protein-bound compounds and larger \"middle molecules\". Newer membranes such as medium cut off membranes (MCO) allow the removal of a wider spectrum of uremic molecules, which reduces the risk of late complications of dialysis. Dialysis membranes are used in therapy methods such as low flux, high flux or HDx therapy. An important aim in dialysis membrane development is to increase their biocompatibility. Insufficient biocompatibility can result in complement activation or platelet activation, which can lead to an increased risk of cardiovascular complications. The aim of the study is to discuss the latest reports on dialysis membranes.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"48 1","pages":"57-63"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36544181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Starch nanoparticles in drug delivery: A review. 淀粉纳米颗粒在药物传递中的研究进展。
Q3 Medicine Pub Date : 2018-01-01 DOI: 10.17219/pim/99993
Michael Ayodele Odeniyi, Omobolanle A Omoteso, Adewale O Adepoju, Kolawole T Jaiyeoba

The uptake and specificity of drugs and the bioavailability of poorly soluble drugs has been improved by means of targeted drug delivery using nanoparticles. Many platforms have been used for nanoparticulate drug delivery and these include liposomes, polymer conjugates, metallic nanoparticles, polymeric micelles, dendrimers, nanoshells, and protein and nucleic acid-based nanoparticles. Starch is the 2nd most abundant natural polymer and has found wide use in drug delivery systems as binder, disintegrant and filler. However, its application is limited by the poor functional properties of native starch. Starch nanocrystals of different shapes and sizes can be obtained based on the starch origin and isolation process involved. Nanocrystals with varying morphology have been reported; from nanocrystals of platelet-like shaped waxy maize starch with 5-7 nm thickness and 15-40 nm diameters, to those with round and grape-like shape from potato starch granules, with sizes ranging from 40 nm to 100 nm. This review describes different methods of obtaining starch nanoparticles, their modification and application in drug delivery.

利用纳米颗粒靶向给药,提高了药物的吸收和特异性以及难溶性药物的生物利用度。许多平台已被用于纳米颗粒药物递送,包括脂质体、聚合物偶联物、金属纳米颗粒、聚合物胶束、树状大分子、纳米壳、蛋白质和核酸基纳米颗粒。淀粉是第二丰富的天然聚合物,作为粘合剂、崩解剂和填料广泛应用于药物输送系统。然而,由于天然淀粉的功能特性较差,限制了其应用。根据淀粉来源和分离过程的不同,可以获得不同形状和大小的淀粉纳米晶体。不同形态的纳米晶体已被报道;从厚度为5-7纳米、直径为15-40纳米的片状糯玉米淀粉纳米晶体,到尺寸为40 - 100纳米的马铃薯淀粉颗粒圆形、葡萄状纳米晶体。本文综述了淀粉纳米颗粒的制备方法、改性及其在药物传递中的应用。
{"title":"Starch nanoparticles in drug delivery: A review.","authors":"Michael Ayodele Odeniyi,&nbsp;Omobolanle A Omoteso,&nbsp;Adewale O Adepoju,&nbsp;Kolawole T Jaiyeoba","doi":"10.17219/pim/99993","DOIUrl":"https://doi.org/10.17219/pim/99993","url":null,"abstract":"<p><p>The uptake and specificity of drugs and the bioavailability of poorly soluble drugs has been improved by means of targeted drug delivery using nanoparticles. Many platforms have been used for nanoparticulate drug delivery and these include liposomes, polymer conjugates, metallic nanoparticles, polymeric micelles, dendrimers, nanoshells, and protein and nucleic acid-based nanoparticles. Starch is the 2nd most abundant natural polymer and has found wide use in drug delivery systems as binder, disintegrant and filler. However, its application is limited by the poor functional properties of native starch. Starch nanocrystals of different shapes and sizes can be obtained based on the starch origin and isolation process involved. Nanocrystals with varying morphology have been reported; from nanocrystals of platelet-like shaped waxy maize starch with 5-7 nm thickness and 15-40 nm diameters, to those with round and grape-like shape from potato starch granules, with sizes ranging from 40 nm to 100 nm. This review describes different methods of obtaining starch nanoparticles, their modification and application in drug delivery.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"48 1","pages":"41-45"},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36876563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 38
[Influence of electrochemical ageing on properties of chosen medical receptacles]. 电化学老化对医用容器性能的影响
Q3 Medicine Pub Date : 2017-07-01 DOI: 10.17219/pim/90021
Adam Gnatowski, Mateusz Chyra, Paulina Walczak

Background: Presently, most of receptacles used in medicine are made of polymeric materials. This is due to, e.g., low price, low weight, and aesthetic values of these materials. The important issue is to ensure long life of polymer in order to protect the medicines closed in the boxes. However, all materials during exploitation are exposed to many factors, which can cause degradation of polymer materials. Degradation processes lead to deterioration of thermomechanical properties of polymers.

Objectives: The aim of this syudy was to examine the influence of electrochemical ageing on properties of polymeric materials used in production of receptacles for drugs and boxes for medical use.

Material and methods: We conducted comparative analysis of samples before and after electrochemical ageing, cut out of receptacles for drugs made from polyethylene, as well as from boxes for medical use and Eppendorf tube made from polypropylene. Investigating methods included differential scanning calorimetry (DSC) and imaging of microstructure ×400 magnification.

Results: We noticed different value of the degree of crystallinity for the aged samples in comparison to not aged samples. The change in value of temperature of physical transformation was also detected. In the aged samples defragmentation of crystal structure was observed.

Conclusions: Electrochemical ageing results in changes of properties of polymeric materials used in production of medical receptacles.

背景:目前,医药用容器多采用高分子材料制成。这是由于这些材料的低价格、低重量和美学价值。重要的问题是确保聚合物的长寿命,以保护封闭在盒子里的药物。然而,所有材料在开发过程中都暴露在许多因素下,这些因素会导致聚合物材料的降解。降解过程导致聚合物热机械性能的恶化。目的:本研究的目的是研究电化学老化对用于生产药品容器和医疗包装盒的聚合物材料性能的影响。材料与方法:我们对电化学老化前后的样品、聚乙烯药品容器、医用包装盒和聚丙烯埃本多夫管剪下的样品进行对比分析。研究方法包括差示扫描量热法(DSC)和显微结构成像×400放大。结果:我们注意到老化样品的结晶度值与未老化样品的结晶度值不同。同时检测了物理转化温度的变化。在时效样品中观察到晶体结构的碎片整理。结论:电化学老化导致医用容器用高分子材料的性能发生变化。
{"title":"[Influence of electrochemical ageing on properties of chosen medical receptacles].","authors":"Adam Gnatowski,&nbsp;Mateusz Chyra,&nbsp;Paulina Walczak","doi":"10.17219/pim/90021","DOIUrl":"https://doi.org/10.17219/pim/90021","url":null,"abstract":"<p><strong>Background: </strong>Presently, most of receptacles used in medicine are made of polymeric materials. This is due to, e.g., low price, low weight, and aesthetic values of these materials. The important issue is to ensure long life of polymer in order to protect the medicines closed in the boxes. However, all materials during exploitation are exposed to many factors, which can cause degradation of polymer materials. Degradation processes lead to deterioration of thermomechanical properties of polymers.</p><p><strong>Objectives: </strong>The aim of this syudy was to examine the influence of electrochemical ageing on properties of polymeric materials used in production of receptacles for drugs and boxes for medical use.</p><p><strong>Material and methods: </strong>We conducted comparative analysis of samples before and after electrochemical ageing, cut out of receptacles for drugs made from polyethylene, as well as from boxes for medical use and Eppendorf tube made from polypropylene. Investigating methods included differential scanning calorimetry (DSC) and imaging of microstructure ×400 magnification.</p><p><strong>Results: </strong>We noticed different value of the degree of crystallinity for the aged samples in comparison to not aged samples. The change in value of temperature of physical transformation was also detected. In the aged samples defragmentation of crystal structure was observed.</p><p><strong>Conclusions: </strong>Electrochemical ageing results in changes of properties of polymeric materials used in production of medical receptacles.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 2","pages":"77-82"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36311998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and evaluation of controlled-release matrix systems of ciprofloxacin. 环丙沙星控释基质体系的研制与评价。
Q3 Medicine Pub Date : 2017-07-01 DOI: 10.17219/pim/90020
Venkata Ramana Malipeddi, Rajendra Awasthi, Kamal Dua

Background: Ciprofloxacin is a broad-spectrum fluoroquinolone antibacterial drug to which most Gram-negative and many Gram-positive bacteria are highly susceptible. Fluoroquinolones are administered repeatedly, twice a day for 5 days, during the course of therapy. Hence, they require repeated administration. Ciprofloxacin qualifies as a drug candidate for a controlled-release drug delivery system.

Objectives: The present work was aimed to develop ciprofloxacin hydrochloride-containing matrix tablets by the wet granulation method.

Material and methods: The tablets were prepared using EthocelTM 100 Premium and Eudragit® RS PO (Evonik Laboratory, Mumbai, India) as a rate-controlling polymer. Granular dioctyl phthalate (DCP) was used as a diluent. An isopropyl alcohol and dichloromethane (1:1) mixture was used as a granulating agent. The effect of the formulation variables on tablet performance was examined based on weight variation, hardness, friability, thickness, and drug release profiles. The results suggested that the tablets had good integrity.

Results: The tablets were stable for 18 months. Formulation F7 gave a linear release pattern up to 12 h. The release of ciprofloxacin from formulation F7 followed zero-order kinetics. The release mechanism was found to be diffusion-controlled as the Higuchi equation was obeyed.

Conclusions: Ciprofloxacin hydrochloride-containing matrix tablets were prepared successfully. The tablets had good integrity and were found stable for 18 months.

背景:环丙沙星是一种广谱氟喹诺酮类抗菌药物,大多数革兰氏阴性菌和许多革兰氏阳性菌对其高度敏感。在治疗过程中,氟喹诺酮类药物重复使用,每天两次,连用5天。因此,它们需要反复管理。环丙沙星有资格作为控释给药系统的候选药物。目的:采用湿法制备盐酸环丙沙星基质片。材料和方法:以EthocelTM 100 Premium和Eudragit®RS PO (Evonik Laboratory, Mumbai, India)为限速聚合物制备片剂。采用颗粒状邻苯二甲酸二辛酯(DCP)作为稀释剂。用异丙醇和二氯甲烷(1:1)的混合物作为造粒剂。根据重量变化、硬度、脆性、厚度和药物释放特性考察了处方变量对片剂性能的影响。结果表明,该片剂具有良好的完整性。结果:片剂稳定性为18个月。F7在12 h内呈线性释放,环丙沙星的释放符合零级动力学。在符合Higuchi方程的情况下,发现其释放机制是扩散控制的。结论:成功制备了盐酸环丙沙星基质片。该片剂具有良好的完整性,18个月稳定。
{"title":"Formulation and evaluation of controlled-release matrix systems of ciprofloxacin.","authors":"Venkata Ramana Malipeddi,&nbsp;Rajendra Awasthi,&nbsp;Kamal Dua","doi":"10.17219/pim/90020","DOIUrl":"https://doi.org/10.17219/pim/90020","url":null,"abstract":"<p><strong>Background: </strong>Ciprofloxacin is a broad-spectrum fluoroquinolone antibacterial drug to which most Gram-negative and many Gram-positive bacteria are highly susceptible. Fluoroquinolones are administered repeatedly, twice a day for 5 days, during the course of therapy. Hence, they require repeated administration. Ciprofloxacin qualifies as a drug candidate for a controlled-release drug delivery system.</p><p><strong>Objectives: </strong>The present work was aimed to develop ciprofloxacin hydrochloride-containing matrix tablets by the wet granulation method.</p><p><strong>Material and methods: </strong>The tablets were prepared using EthocelTM 100 Premium and Eudragit® RS PO (Evonik Laboratory, Mumbai, India) as a rate-controlling polymer. Granular dioctyl phthalate (DCP) was used as a diluent. An isopropyl alcohol and dichloromethane (1:1) mixture was used as a granulating agent. The effect of the formulation variables on tablet performance was examined based on weight variation, hardness, friability, thickness, and drug release profiles. The results suggested that the tablets had good integrity.</p><p><strong>Results: </strong>The tablets were stable for 18 months. Formulation F7 gave a linear release pattern up to 12 h. The release of ciprofloxacin from formulation F7 followed zero-order kinetics. The release mechanism was found to be diffusion-controlled as the Higuchi equation was obeyed.</p><p><strong>Conclusions: </strong>Ciprofloxacin hydrochloride-containing matrix tablets were prepared successfully. The tablets had good integrity and were found stable for 18 months.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 2","pages":"101-106"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36312002","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Kheri (Acacia chundra, family: Mimosaceae) gum: Characterization using analytical, mathematical and pharmaceutical approaches. Kheri(金合欢,含羞草科)胶:用分析、数学和药学方法表征。
Q3 Medicine Pub Date : 2017-07-01 DOI: 10.17219/pim/76515
Rishabha Malviya, Pramod Sharma, Susheel Dubey

Background: Natural polymers have been used in medical, pharmaceutical, cosmetic and food industry. They should be characterized before their possible applications in different industries.

Objectives: The objective of this study was to characterize Kheri (Acacia chundra, family: Mimosaceae) gum using analytical, mathematical and pharmaceutical approaches.

Material and methods: Crude Kheri gum (KG) was purified using distilled water as a solvent and ethanol as a precipitating agent. KG was characterized in terms of phytochemical screening, micromeritic properties, microbial load, ash value, rheological behavior, solid state 1H nuclear magnetic resonance (NMR), mass spectra and Fourier-transform infrared spectroscopy (FTIR) studies for their possible applications in food, cosmetics and pharmaceutical industry.

Results: Studies show that KG contains carbohydrates, while protein, fat, volatile oils, alkaloids and glycosides are absent. 1% aqueous solution of polysaccharide showed 25.58 × 103 kJ/kg activation energy and 1.39 Reynold's number. Viscosity average molecular weight of purified gum was found 1.73 × 105 D. Thermodynamic parameters, i.e., change in enthalpy ΔHv and change in enthalpy ΔHv, were found to be 12.26 × 103 kJ/mol and 24.47 kJ/mol, respectively. Mathematical approach also determined the rod shaped conformation of KG in aqueous solution. IR spectroscopic study shows the presence of free (COO-) and esterified (COO-R) carboxylic acid, ether (C-O stretching), galacturonic acid and mannose in polysaccharide 1H NMR study predicts presence of tetrahydropyran hydrogen in molecule. Furthermore, KG was also characterized as a suspending agent using paracetamol as a model drug. Flow rate, pH, particle size and settling behavior of suspensions were evaluated. Initial particle size of dispersed phase particles does not change significantly after 45 days.

Conclusions: From the findings of the research it can be concluded that KG can be used as an excipient in cosmaceuticals and pharmaceuticals and its characteristic rheological behavior may attract rheologists.

背景:天然聚合物在医疗、制药、化妆品和食品工业中有着广泛的应用。在它们可能应用于不同的行业之前,应该对它们进行表征。目的:本研究的目的是利用分析,数学和药学方法表征Kheri(金合欢,含羞草科)口香糖。材料和方法:以蒸馏水为溶剂,乙醇为沉淀剂,对粗卡立胶(KG)进行纯化。从植物化学筛选、微分学性质、微生物负荷、灰分值、流变学行为、固体1H核磁共振(NMR)、质谱和傅里叶变换红外光谱(FTIR)等方面对其进行了表征,展望了其在食品、化妆品和制药行业的应用前景。结果:研究表明,KG含有碳水化合物,不含蛋白质、脂肪、挥发油、生物碱和糖苷。多糖1%水溶液的活化能为25.58 × 103 kJ/kg,雷诺数为1.39。所得纯化胶的黏度平均分子量为1.73 × 105 d,热力学参数焓变ΔHv和焓变ΔHv分别为12.26 × 103 kJ/mol和24.47 kJ/mol。用数学方法确定了KG在水溶液中的棒状构象。红外光谱研究表明多糖中存在游离(COO-)和酯化(COO- r)羧酸、醚(C-O拉伸)、半乳糖醛酸和甘露糖。1H NMR研究预测分子中存在四氢吡喃氢。此外,KG还被表征为一种悬浮剂,以扑热息痛为模型药物。对悬浮液的流速、pH、粒径和沉降行为进行了评价。45天后分散相颗粒的初始粒径变化不明显。结论:KG可作为药妆和药品的赋形剂,其独特的流变特性可吸引流变学家的注意。
{"title":"Kheri (Acacia chundra, family: Mimosaceae) gum: Characterization using analytical, mathematical and pharmaceutical approaches.","authors":"Rishabha Malviya,&nbsp;Pramod Sharma,&nbsp;Susheel Dubey","doi":"10.17219/pim/76515","DOIUrl":"https://doi.org/10.17219/pim/76515","url":null,"abstract":"<p><strong>Background: </strong>Natural polymers have been used in medical, pharmaceutical, cosmetic and food industry. They should be characterized before their possible applications in different industries.</p><p><strong>Objectives: </strong>The objective of this study was to characterize Kheri (Acacia chundra, family: Mimosaceae) gum using analytical, mathematical and pharmaceutical approaches.</p><p><strong>Material and methods: </strong>Crude Kheri gum (KG) was purified using distilled water as a solvent and ethanol as a precipitating agent. KG was characterized in terms of phytochemical screening, micromeritic properties, microbial load, ash value, rheological behavior, solid state 1H nuclear magnetic resonance (NMR), mass spectra and Fourier-transform infrared spectroscopy (FTIR) studies for their possible applications in food, cosmetics and pharmaceutical industry.</p><p><strong>Results: </strong>Studies show that KG contains carbohydrates, while protein, fat, volatile oils, alkaloids and glycosides are absent. 1% aqueous solution of polysaccharide showed 25.58 × 103 kJ/kg activation energy and 1.39 Reynold's number. Viscosity average molecular weight of purified gum was found 1.73 × 105 D. Thermodynamic parameters, i.e., change in enthalpy ΔHv and change in enthalpy ΔHv, were found to be 12.26 × 103 kJ/mol and 24.47 kJ/mol, respectively. Mathematical approach also determined the rod shaped conformation of KG in aqueous solution. IR spectroscopic study shows the presence of free (COO-) and esterified (COO-R) carboxylic acid, ether (C-O stretching), galacturonic acid and mannose in polysaccharide 1H NMR study predicts presence of tetrahydropyran hydrogen in molecule. Furthermore, KG was also characterized as a suspending agent using paracetamol as a model drug. Flow rate, pH, particle size and settling behavior of suspensions were evaluated. Initial particle size of dispersed phase particles does not change significantly after 45 days.</p><p><strong>Conclusions: </strong>From the findings of the research it can be concluded that KG can be used as an excipient in cosmaceuticals and pharmaceuticals and its characteristic rheological behavior may attract rheologists.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 2","pages":"65-76"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36313389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Improving the solubility of nevirapine using A hydrotropy and mixed hydrotropy based solid dispersion approach. 用A型亲水性和混合亲水性的固体分散方法改善奈韦拉平的溶解度。
Q3 Medicine Pub Date : 2017-07-01 DOI: 10.17219/pim/77093
Jyotsana R Madan, Virendra J Kamate, Kamal Dua, Rajendra Awasthi

Background: Nevirapine, an antiviral drug, is a potent reverse transcriptase inhibitor (NNRTI). It is used in combination with nucleoside analogues for treatment of HIV type-1 (HIV-1) infection and AIDS. Nevirapine is a BCS class II drug which shows dissolution rate limited absorption.

Objectives: The aim of the present research was to provide a fast dissolving solid dispersion of nevirapine.

Material and methods: The solubility of nevirapine was initially determined individually in four hydrotropic agents - namely urea, lactose, citric acid and mannitol - at a concentration of 10, 20, 30 and 40% w/v solutions using purified water as a solvent. The highest solubility was obtained in the 40% citric acid solution. Then different combinations of 2 and 3 hydrotropic agents in different ratios were used to determine solubility, so that the total concentration of hydrotropic agents was always 40%.

Results: The highest solubility was obtained in a solution of lactose and citric acid at the optimum ratio of 15:25. This optimized combination was utilized in preparing solid dispersions by a common solvent technique using distilled water as a solvent. The solid dispersions were evaluated for XRD, DSC and FTIR to show no drug-hydrotrope interaction.

Conclusions: It was concluded that the concept of mixed hydrotropic solid dispersion is a safe, novel and cost-effective technique for enhancing the bioavailability of poorly water-soluble drugs by dissolving the drug in a nonionized form. The enhancement in solubility of nevirapine using hydrotropy is a clear indication of its potential to be used in the future for other poorly water-soluble drugs in which low bioavailability is a major concern.

背景:抗病毒药物奈韦拉平是一种有效的逆转录酶抑制剂(NNRTI)。它与核苷类似物联合用于治疗1型HIV (HIV-1)感染和艾滋病。奈韦拉平为BCSⅱ类药物,溶出率有限,吸收有限。目的:本研究的目的是提供奈韦拉平的快速溶解固体分散体。材料和方法:最初分别测定奈韦拉平在四种亲水剂中的溶解度,即尿素、乳糖、柠檬酸和甘露醇,浓度分别为10、20、30和40% w/v,使用纯净水作为溶剂。在40%柠檬酸溶液中溶解度最高。然后用2、3种亲水性剂以不同比例组合测定溶解度,使亲水性剂总浓度始终为40%。结果:乳酸菌在乳糖与柠檬酸溶液中溶解度最高,最佳配比为15:25。该优化组合以蒸馏水为溶剂,采用普通溶剂技术制备固体分散体。通过XRD、DSC和FTIR对固体分散体进行了评价,表明无药物-水相相互作用。结论:混合亲水固体分散体是一种安全、新颖、经济的方法,可通过非离子化方式溶解难溶性药物,提高药物的生物利用度。奈韦拉平的溶解度利用亲和性的增强是一个明确的指示,它有可能在未来用于其他低生物利用度是主要问题的低水溶性药物。
{"title":"Improving the solubility of nevirapine using A hydrotropy and mixed hydrotropy based solid dispersion approach.","authors":"Jyotsana R Madan,&nbsp;Virendra J Kamate,&nbsp;Kamal Dua,&nbsp;Rajendra Awasthi","doi":"10.17219/pim/77093","DOIUrl":"https://doi.org/10.17219/pim/77093","url":null,"abstract":"<p><strong>Background: </strong>Nevirapine, an antiviral drug, is a potent reverse transcriptase inhibitor (NNRTI). It is used in combination with nucleoside analogues for treatment of HIV type-1 (HIV-1) infection and AIDS. Nevirapine is a BCS class II drug which shows dissolution rate limited absorption.</p><p><strong>Objectives: </strong>The aim of the present research was to provide a fast dissolving solid dispersion of nevirapine.</p><p><strong>Material and methods: </strong>The solubility of nevirapine was initially determined individually in four hydrotropic agents - namely urea, lactose, citric acid and mannitol - at a concentration of 10, 20, 30 and 40% w/v solutions using purified water as a solvent. The highest solubility was obtained in the 40% citric acid solution. Then different combinations of 2 and 3 hydrotropic agents in different ratios were used to determine solubility, so that the total concentration of hydrotropic agents was always 40%.</p><p><strong>Results: </strong>The highest solubility was obtained in a solution of lactose and citric acid at the optimum ratio of 15:25. This optimized combination was utilized in preparing solid dispersions by a common solvent technique using distilled water as a solvent. The solid dispersions were evaluated for XRD, DSC and FTIR to show no drug-hydrotrope interaction.</p><p><strong>Conclusions: </strong>It was concluded that the concept of mixed hydrotropic solid dispersion is a safe, novel and cost-effective technique for enhancing the bioavailability of poorly water-soluble drugs by dissolving the drug in a nonionized form. The enhancement in solubility of nevirapine using hydrotropy is a clear indication of its potential to be used in the future for other poorly water-soluble drugs in which low bioavailability is a major concern.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 2","pages":"83-90"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36312000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 19
Light-cured dimethacrylate dental restorative composites under a prism of annihilating positrons. 光固化二甲基丙烯酸酯牙齿修复复合材料下的棱镜湮灭正电子。
Q3 Medicine Pub Date : 2017-07-01 DOI: 10.17219/pim/81450
Olha Shpotyuk, Adam Ingram, Oleh Shpotyuk, Elvira Bezvushko

Background: Breakthrough resolutions in current biopolymer engineering rely on reliable diagnostics of atomic-deficient spaces over the finest sub-nanometer length scales. One such diagnostic is positron annihilation lifetime spectroscopy, which probes space-time continuum relationships for the interaction between electrons and their antiparticle (positrons) in structural entities like free-volume defects, vacancies, vacancy-like clusters, interfacial voids and pores, etc.

Objectives: This paper is intended to highlight the possibilities of positron annihilation lifetime spectroscopy as an informative instrumentation tool to parameterize free-volume evolution in light-cured dimethacrylate dental restorative composites exemplified by Charisma® (Heraeus Kulzer GmbH, Hanau, Germany) and Dipol® (Oksomat-AN Ltd, Kyiv, Ukraine).

Material and methods: The subjects of the study were the commercially available dimethacrylate-type dental restorative composites Charisma® and Dipol®. The analysis used a fast-fast coincidence system of 230 ps resolution based on 2 photomultiplier tubes coupled to BaF2 scintillator detectors and ORTEC® (ORTEC, Oak Ridge, USA) electronics to register lifetime spectra in normal-measurement statistics evolving ~1 million coincidences.

Results: The annihilation process in both composites is identified as mixed positron-Ps (positronium) trapping, where ortho-Ps decaying is caused entirely by free-volume holes in the polymer matrix, and the 2nd component is defined mainly by interfacial free-volume holes between filler nanoparticles and the surrounding polymer. The most appropriate model-independent estimation of photopolymerization volumetric shrinkage in dental restorative composites can be done using averaged positron annihilation lifetime. Partiallyconstrained x4-term analysis of lifetime spectra is less efficient, giving greater scatter of variance with an additional artifact of fixed shortest lifetime allowing unresolved mixing in the 2nd component. A meaningful phenomenological description of transformations in Ps and positron-trapping sites under light curing, which occurs more efficiently in Charisma® than in Dipol® nanocomposites, can be developed at the basis of a semi-empirical model exploring a x3-x2-coupling decomposition algorithm.

Conclusions: A deep understanding of void-evolution processes in dimethacrylate dental composites employing positron annihilation lifetime spectroscopy makes it possible to diagnose, characterize and engineer novel biomaterials for advanced use in medical practice.

背景:当前生物聚合物工程的突破性解决方案依赖于在最精细的亚纳米长度尺度上对原子缺陷空间的可靠诊断。其中一种诊断方法是正电子湮灭寿命谱,它探测电子和它们的反粒子(正电子)在自由体积缺陷、空位、类空位团簇、界面空隙和孔隙等结构实体中相互作用的时空连续关系。本文旨在强调正电子湮灭寿命光谱作为一种信息仪器工具的可能性,以参数化光固化二甲基丙烯酸酯牙科修复复合材料的自由体积演变为例,如Charisma®(Heraeus Kulzer GmbH, Hanau, Germany)和Dipol®(Oksomat-AN Ltd, Kyiv, Ukraine)。材料和方法:研究对象为市售的二甲基丙烯酸酯型牙科修复复合材料Charisma®和Dipol®。该分析使用了一个230 ps分辨率的快速重合系统,该系统基于2个光电倍增管耦合到BaF2闪烁体探测器和ORTEC®(ORTEC, Oak Ridge, USA)电子设备,以正常测量统计数据记录寿命光谱,进化到100万次重合。结果:两种复合材料的湮灭过程均为正电子- ps(正电子)混合捕获,其中正电子- ps衰变完全由聚合物基体中的自由体积空穴引起,第二组分主要由填料纳米颗粒与周围聚合物之间的界面自由体积空穴确定。用平均正电子湮灭寿命来估计牙科修复复合材料的光聚合体积收缩是最合适的模型独立估计。部分受限的寿命谱的x4项分析效率较低,给出了更大的方差散射与固定的最短寿命的额外工件,允许在第二组分中未解决的混合。在探索x3-x2耦合分解算法的半经验模型的基础上,可以对光固化下Ps和正电子捕获位点的转换进行有意义的现象学描述,这种转换在Charisma®纳米复合材料中比在Dipol®纳米复合材料中更有效。结论:利用正电子湮灭寿命谱对二甲基丙烯酸酯牙科复合材料中空隙演化过程的深入了解,使诊断、表征和设计新型生物材料成为可能,并在医疗实践中得到先进应用。
{"title":"Light-cured dimethacrylate dental restorative composites under a prism of annihilating positrons.","authors":"Olha Shpotyuk,&nbsp;Adam Ingram,&nbsp;Oleh Shpotyuk,&nbsp;Elvira Bezvushko","doi":"10.17219/pim/81450","DOIUrl":"https://doi.org/10.17219/pim/81450","url":null,"abstract":"<p><strong>Background: </strong>Breakthrough resolutions in current biopolymer engineering rely on reliable diagnostics of atomic-deficient spaces over the finest sub-nanometer length scales. One such diagnostic is positron annihilation lifetime spectroscopy, which probes space-time continuum relationships for the interaction between electrons and their antiparticle (positrons) in structural entities like free-volume defects, vacancies, vacancy-like clusters, interfacial voids and pores, etc.</p><p><strong>Objectives: </strong>This paper is intended to highlight the possibilities of positron annihilation lifetime spectroscopy as an informative instrumentation tool to parameterize free-volume evolution in light-cured dimethacrylate dental restorative composites exemplified by Charisma® (Heraeus Kulzer GmbH, Hanau, Germany) and Dipol® (Oksomat-AN Ltd, Kyiv, Ukraine).</p><p><strong>Material and methods: </strong>The subjects of the study were the commercially available dimethacrylate-type dental restorative composites Charisma® and Dipol®. The analysis used a fast-fast coincidence system of 230 ps resolution based on 2 photomultiplier tubes coupled to BaF2 scintillator detectors and ORTEC® (ORTEC, Oak Ridge, USA) electronics to register lifetime spectra in normal-measurement statistics evolving ~1 million coincidences.</p><p><strong>Results: </strong>The annihilation process in both composites is identified as mixed positron-Ps (positronium) trapping, where ortho-Ps decaying is caused entirely by free-volume holes in the polymer matrix, and the 2nd component is defined mainly by interfacial free-volume holes between filler nanoparticles and the surrounding polymer. The most appropriate model-independent estimation of photopolymerization volumetric shrinkage in dental restorative composites can be done using averaged positron annihilation lifetime. Partiallyconstrained x4-term analysis of lifetime spectra is less efficient, giving greater scatter of variance with an additional artifact of fixed shortest lifetime allowing unresolved mixing in the 2nd component. A meaningful phenomenological description of transformations in Ps and positron-trapping sites under light curing, which occurs more efficiently in Charisma® than in Dipol® nanocomposites, can be developed at the basis of a semi-empirical model exploring a x3-x2-coupling decomposition algorithm.</p><p><strong>Conclusions: </strong>A deep understanding of void-evolution processes in dimethacrylate dental composites employing positron annihilation lifetime spectroscopy makes it possible to diagnose, characterize and engineer novel biomaterials for advanced use in medical practice.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 2","pages":"91-100"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36312001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Buccal patches of atenolol formulated using fenugreek (Trigonella foenum-graecum L.) seed mucilage. 用胡芦巴(葫芦巴)种子粘液配制的阿替洛尔口腔贴片。
Q3 Medicine Pub Date : 2017-01-01 DOI: 10.17219/pim/70498
Surya Narayan Ratha Adhikari, Satyabrata Panda

Background: The use of mucoadhesive natural polymers in designing mucoadhesive patch systems has received much attention.

Objectives: The study involved the development and evaluation of buccal patches of atenolol using fenugreek (Trigonella foenum-graecum L.) seed mucilage with hydroxylpropyl methyl cellulose (HPMC K4M) and a backing membrane (ethyl cellulose 5% w/v).

Material and methods: These atenolol-releasing buccal patches were prepared using a solvent casting technique. The buccal patches prepared were evaluated for average weight, thickness, drug content, folding endurance and moisture content. Ex vivo mucoadhesive strength, force of adhesion and bonding strength were determined using porcine buccal mucosa. The mucosal permeation of atenolol through the porcine buccal mucosa was carried out using a Franz diffusion cell in phosphate buffer saline, pH 6.8. These buccal patches were also characterized by SEM and FTIR spectroscopy.

Results: The average weight, thickness, drug content, folding endurance and moisture content of these atenolol-releasing buccal patches were found satisfactory for all the patches. Amongst all, the F-4 buccal patch showed maximum mucoadhesive strength (31.12 ±1.86 g), force of adhesion (30.53 × 10-2 N) and bond strength (1748.89 N/m2). Ex vivo atenolol permeation from the buccal patches showed drug permeation across the excised porcine buccal mucosa over 12 h. The F-4 buccal patch showed maximum permeation flux (29.12 μg/cm2/h).

Conclusions: The developed atenolol-releasing buccal patches can be beneficial over the conventional drug delivery systems to decrease the dosing frequency and enhance patient compliance.

背景:利用天然黏附聚合物设计黏附贴片系统已受到广泛关注。目的:利用胡芦巴种子黏液和羟丙基甲基纤维素(HPMC - K4M)和背膜(乙基纤维素5% w/v)制备阿替洛尔口腔贴剂。材料与方法:采用溶剂铸造法制备阿替洛尔口腔贴片。对制备的口腔贴片的平均重量、厚度、药物含量、折叠耐力和水分含量进行评价。以猪口腔黏膜为材料,测定其离体黏附强度、黏附力和粘接强度。采用Franz扩散池,在pH为6.8的磷酸盐缓冲盐水中检测阿替洛尔对猪颊黏膜的粘膜渗透。用扫描电镜(SEM)和红外光谱(FTIR)对口腔斑块进行了表征。结果:所制备的阿替洛尔口腔释放贴片的平均重量、厚度、药物含量、折叠时间和水分含量均较理想。其中,F-4型颊贴黏附强度最大(31.12±1.86 g),黏附力最大(30.53 × 10-2 N),粘接强度最大(1748.89 N/m2)。口腔贴片的体外阿替洛尔透入显示药物在12 h内通过切除的猪口腔粘膜,其中F-4口腔贴片的透入通量最大(29.12 μg/cm2/h)。结论:研制的阿替洛尔口腔贴片比传统给药系统更有利于降低给药频率,提高患者依从性。
{"title":"Buccal patches of atenolol formulated using fenugreek (Trigonella foenum-graecum L.) seed mucilage.","authors":"Surya Narayan Ratha Adhikari,&nbsp;Satyabrata Panda","doi":"10.17219/pim/70498","DOIUrl":"https://doi.org/10.17219/pim/70498","url":null,"abstract":"<p><strong>Background: </strong>The use of mucoadhesive natural polymers in designing mucoadhesive patch systems has received much attention.</p><p><strong>Objectives: </strong>The study involved the development and evaluation of buccal patches of atenolol using fenugreek (Trigonella foenum-graecum L.) seed mucilage with hydroxylpropyl methyl cellulose (HPMC K4M) and a backing membrane (ethyl cellulose 5% w/v).</p><p><strong>Material and methods: </strong>These atenolol-releasing buccal patches were prepared using a solvent casting technique. The buccal patches prepared were evaluated for average weight, thickness, drug content, folding endurance and moisture content. Ex vivo mucoadhesive strength, force of adhesion and bonding strength were determined using porcine buccal mucosa. The mucosal permeation of atenolol through the porcine buccal mucosa was carried out using a Franz diffusion cell in phosphate buffer saline, pH 6.8. These buccal patches were also characterized by SEM and FTIR spectroscopy.</p><p><strong>Results: </strong>The average weight, thickness, drug content, folding endurance and moisture content of these atenolol-releasing buccal patches were found satisfactory for all the patches. Amongst all, the F-4 buccal patch showed maximum mucoadhesive strength (31.12 ±1.86 g), force of adhesion (30.53 × 10-2 N) and bond strength (1748.89 N/m2). Ex vivo atenolol permeation from the buccal patches showed drug permeation across the excised porcine buccal mucosa over 12 h. The F-4 buccal patch showed maximum permeation flux (29.12 μg/cm2/h).</p><p><strong>Conclusions: </strong>The developed atenolol-releasing buccal patches can be beneficial over the conventional drug delivery systems to decrease the dosing frequency and enhance patient compliance.</p>","PeriodicalId":20355,"journal":{"name":"Polimery w medycynie","volume":"47 1","pages":"5-11"},"PeriodicalIF":0.0,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35572546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
期刊
Polimery w medycynie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1